Correction to : Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy by Wadsley et al. Thyroid 2023;33(9):1119–1123;doi: 10.1089/thy.2022.0707

In the September 2023 issue of Thyroid (vol. 33, no. 9; pp. 1119–1123) the article entitled “Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy” by Wadsley et al. requires correction.

This article was originally published under the copyright of Mary Ann Liebert, Inc. publishers. It has now been updated to reflect Open Access, with copyright transferring to the author(s), and a Creative Commons License (CC-BY) added (http://creativecommons.org/licenses/by/4.0). The CC-BY license went into effect October 16, 2023.

The online version of this article has been corrected to reflect this.